Atopic Dermatitis
Latest News
Phase3 Data: Atopic Dermatitis Symptoms Improved with Topical Roflumilast
The primary efficacy endpoint was the Validated Investigator Global Assessment for AD (vIGA-AD) success at week 4.
Latest News
Biomarkers in Cord Blood May Predict AD Onset in Newborns, Study Suggests
In the study, infants with signs of AD had significantly higher TEWL levels at the anterior cubital fossa at 1, 6, and 12 months than those...
Latest News
New Options for Treating Atopic Dermatitis Available, and in Development
The current pipeline for AD includes 39 injectable medications, 21 oral agents, and 49 topicals, according to the National Eczema Association.
Latest News
Study Helps Define Patient-Centered Definition of Atopic Dermatitis Flares
A focus group reached consensus on 15 statements, and survey participants reached consensus on 12 of those statements defining an AD flare.
Latest News
Storybooks Can Help Children Deal with Skin Conditions
“There are tools to help kids cope with their skin conditions, but we’re underutilizing them,” Dr. Sonia Havele said.
Latest News
Nemolizumab Benefits Seen in Adults, Teens With Atopic Dermatitis
Significant improvements in pruritus were observed as early as week 1, with a greater proportion of participants in the nemolizumab vs placebo...
Latest News
Study Identifies Oral Antibiotics Linked to Severe Cutaneous Reactions
The results “underscore the importance of judicious prescribing, with preferential use of antibiotics associated with a lower risk when clinically...
Latest News
Several Skin Conditions More Likely in Children With Obesity
Investigators collected data on several skin conditions and comorbidities in a retrospective cohort study.
Latest News
Studies Show Dupilumab Effects In Children with Both Atopic Dermatitis and Alopecia
Overall, 77.4% of patients in the trials achieved hair regrowth with dupilumab treatment.
Latest News
Topical PDE4 Inhibitor Now Approved for Atopic Dermatitis in Children, Adults
Among children and adults who participated in the INTEGUMENT studies for 28 and 56 weeks, 61.3% and 65.7% saw a 75% reduction in their Eczema Area...
Latest News
Atopic Dermatitis: Study Compares Prevalence by Gender, Age, and Ethnic Background
“Results are important for us to consider targeted strategies to address AD burden,” said Raj Chovatiya, MD, PhD....